WILLIAMS AND JENSEN, PLLC for MERCK & CO INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
International trade issues and agreements; Monitor pending trade issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax including international tax proposals; tax Reform proposal.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | COS, Rep Van Hilleary and Majority Whip |
| CHERYL LYNN JAEGER | — |
| NICHOLAS KARELLAS New | LA to Senator Christopher Bond; Tax Counsel, Rep Lynn Jenkins |
| KARINA LYNCH | — |
Medicare/Medicaid MMM
Payment policies for Part B prescription drugs; rebates and co-pays for Medicare Part D drug benefits; possible revisions in structure and operation of Medicare Drug policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | Shared employee, Ofc of the Speaker and Ofc of VA 7th; Sr Policy Advisor, Majority Leader, Rep. Eric Cantor; Sr. Advisor, Majority Whip, Rep Roy Blunt; Prof Staff House Committee on E&C; Sr LA to Rep. Christopher Cox |
| KARINA LYNCH | — |
Animals ANI
Monitor trade issues as they relate to animal health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT GRAVES New | Deputy Chief of Staff, Rep Conaway; COS, Rep Farenthold, COS, Rep Conaway; Staff Director, House Ag Committee |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov Affairs. |
| ERIN BOOK MULLEN New | — |
Health Issues HCR
Drug safety; Congressional oversight issues; Issues related to vaccines and drug pricing; Drug pricing under 340B program; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; general education about FDA approval policies; S. 204, Trickett Wendler Right to Try Act; H.R. 878, Right to Try Act of 2017; H.R. 2430, S. 934, FDA Reauthorization Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.